TransDerm Awarded $4M Grant to Develop RNAi Treatment for Skin Disease
September 29, 2011
TransDerm Awarded $4M Grant to Develop RNAi Treatment for Skin Disease
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIH Awards $1.2M in Grants to Four Companies Developing RNAi, miRNA Cancer Drugs
October 4, 2012 / Gene Silencing News - TransDerm Preps for New Phase I Trial with New RNAi Drug, Delivery System
June 7, 2012 / Gene Silencing News - NIH Awards Four Grants in February to Advance Research in siRNA Delivery, miRNA Function
February 24, 2011 / Gene Silencing News - TransDerm Inks Research Deal with RXi, Gets Grant to Explore Delivery Technologies
April 8, 2010 / Gene Silencing News - Rockefeller, OSU miRNA Researchers Pull in Big Bucks Under Recovery Act
October 22, 2009 / Gene Silencing News